Results 151 to 160 of about 205,182 (367)
The Rationale for Performing Autologous Peripheral Blood Stem Cell Transplants in Community Cancer Centers [PDF]
Charles H. Weaver+4 more
openalex +1 more source
ABSTRACT Background Whole abdominal radiotherapy (WART) is utilized in children, adolescents, and young adults with intra‐abdominal sarcoma, but efficacy and toxicity are uncertain. Methods Sarcoma patients diagnosed at ≤39 years of age between 1998 and 2023 who received WART were identified from a national registry.
Rebecca J. Deyell+12 more
wiley +1 more source
A comparison of CD34+ cell selected and unselected autologous peripheral blood stem cell transplantation for multiple myeloma: a case controlled analysis [PDF]
Maher K. Gandhi+6 more
openalex +1 more source
Autologous stem cell transplantation in a patient with scleromyxedema
Sunita Nathan, Celalettin Ustun
openaire +3 more sources
ABSTRACT Background Food safety practices are widely recommended for pediatric patients with cancer or undergoing hematopoietic stem cell transplantation (HCT) to mitigate foodborne infectious risks. However, specific measures, such as the neutropenic diet (ND) or low‐microbial diet, lack robust evidence and are inconsistently implemented across ...
Davide Leardini+28 more
wiley +1 more source
Post-traumatic Stress Symptoms in Patients Undergoing Autologous Stem Cell Transplantation [PDF]
Lena Wettergren+3 more
openalex +1 more source
Pegfilgrastim in Autologous Stem Cell Transplant [PDF]
Nancy Cody Lyons+2 more
openaire +2 more sources
How I Approach Ethical Considerations for Pediatric Phase I CAR T‐Cell Trials
ABSTRACT Phase I trials of chimeric antigen receptor (CAR) T cells have shown remarkable promise in pediatric B‐cell malignancies. Such outcomes have shifted expectations for other phase I CAR T‐cell trials to have high response rates. The juxtaposition of high expectations, uncertain outcomes, and potential for life‐threatening toxicities raises ...
Sarah W. Peters+6 more
wiley +1 more source
We present the method of immunomagnetic stem cell separation with the ISOLEX 300i device (Isolex® 300i Magnetic Cell Selection System, Nextell Therapeutics Inc.
Benedek István+5 more
doaj +1 more source
Stem Cells: The Good, the Bad and the Ugly [PDF]
Cancer stem cells are controlled by developmental networks that are often topologically indistinguishable from normal, healthy stem cells. The question is why cancer stem cells can be both phenotypically distinct and have morphological effects so different from normal stem cells.
arxiv